Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s ... the need for the off-brand versions. “We conclude that the information and data Lilly has provided to ...

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

Mediar Therapeutics has entered a global licensing agreement with Eli Lilly and Company to progress the human immunoglobulin ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide ...

The FDA has issued warnings against the off-brand versions ... and Mounjaro could be affected as a result of the move. The Eli Lilly logo is shown on one of the company's offices in San Diego ...